Second, the lack of detection results of glycosylated hemoglobin A1C, insulin level, TNF-α, IFN, IL-1β, and other cytokines limited the deeper assessment of glycemia and immune dysfunction in COVID-19 patients with T2DM. The gene discussed is INS; the disease is COVID-19.